E Fund Management Co., Ltd. Apellis Pharmaceuticals, Inc. Transaction History
E Fund Management Co., Ltd.
- $2.07 Billion
- Q1 2025
A detailed history of E Fund Management Co., Ltd. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 16,835 shares of APLS stock, worth $319,023. This represents 0.02% of its overall portfolio holdings.
Number of Shares
16,835
Previous 17,162
1.91%
Holding current value
$319,023
Previous $547,000
32.72%
% of portfolio
0.02%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding APLS
# of Institutions
286Shares Held
124MCall Options Held
921KPut Options Held
761K-
Wellington Management Group LLP Boston, MA12.3MShares$233 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.2MShares$232 Million4.32% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$225 Million20.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$192 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.63MShares$182 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.08B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...